KRTAP4-8
gene geneOn this page
Also known as KAP4.8
Summary
KRTAP4-8 (keratin associated protein 4-8, HGNC:17230) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 4-8 (Q9BYQ9). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Involved in hair cycle. Predicted to be located in cytosol.
Source: NCBI Gene 728224 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_031960
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17230 |
| Approved symbol | KRTAP4-8 |
| Name | keratin associated protein 4-8 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP4.8 |
| Ensembl gene | ENSG00000204880 |
| Ensembl biotype | protein_coding |
| Entrez | 728224 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000333822
RefSeq mRNA: 1 — MANE Select: NM_031960
NM_031960
CCDS: CCDS45674
Canonical transcript exons
ENST00000333822 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533292 | 41096981 | 41098142 |
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 38.59.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0692 / max 40.7113, expressed in 14 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165873 | 0.0692 | 14 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 38.59 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| zone of skin | UBERON:0000014 | 36.78 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skin of leg | UBERON:0001511 | 35.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| sural nerve | UBERON:0015488 | 35.37 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| right lung | UBERON:0002167 | 30.62 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.28 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.21 | gold quality |
| blood | UBERON:0000178 | 28.58 | silver quality |
| cortex of kidney | UBERON:0001225 | 28.23 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| muscle of leg | UBERON:0001383 | 27.27 | gold quality |
| leukocyte | CL:0000738 | 27.16 | gold quality |
| monocyte | CL:0000576 | 27.12 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| kidney | UBERON:0002113 | 26.93 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| gastrocnemius | UBERON:0001388 | 26.50 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
60 targeting KRTAP4-8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-3681-5P | 99.82 | 66.88 | 387 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-3660 | 99.68 | 67.33 | 1149 |
| HSA-MIR-4526 | 99.68 | 67.07 | 1136 |
| HSA-MIR-6849-5P | 99.64 | 66.00 | 352 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap5-2 | ENSMUSG00000054759 |
| mus_musculus | Krtap5-20 | ENSMUSG00000056885 |
| mus_musculus | Krtap5-26 | ENSMUSG00000109859 |
| mus_musculus | Krtap5-24 | ENSMUSG00000110324 |
| rattus_norvegicus | Krtap5-8 | ENSRNOG00000020131 |
| rattus_norvegicus | AABR07006049.1 | ENSRNOG00000046649 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 4-8 — Q9BYQ9 (reviewed: Q9BYQ9)
Alternative names: Keratin-associated protein 4.8, Ultrahigh sulfur keratin-associated protein 4.8
All UniProt accessions (1): Q9BYQ9
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Expressed in the hair follicles.
Polymorphism. Numerous size polymorphism are present in KRTAP4 gene family, which are mainly due to variations in the sequence encoding cysteine-rich repeat segments. The sequence shown corresponds to allele KAP4.8-v1.
Similarity. Belongs to the KRTAP type 4 family.
RefSeq proteins (1): NP_114166* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF13885
UniProt features (31 total): repeat 25, sequence conflict 4, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYQ9-F1 | 34.97 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 29 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_MOLTING_CYCLE, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR3646, MIR4698, MIR3133, MIR338_5P, MIR655_3P, MIR374C_5P, MIR5196_5P
GO Biological Process (1): hair cycle (GO:0042633)
GO Molecular Function (0):
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| molting cycle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
210 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP4-8 | A0A3B3IRQ3 | A0A3B3IRQ3 | 583 |
| KRTAP4-8 | DEPDC4 | Q8N2C3 | 581 |
| KRTAP4-8 | SLC35G6 | P0C7Q6 | 507 |
| KRTAP4-8 | LYSET | Q8N6I4 | 492 |
| KRTAP4-8 | NPIPB12 | F8W0I5 | 479 |
| KRTAP4-8 | POTEC | B2RU33 | 447 |
| KRTAP4-8 | NPIPB4 | C9JG80 | 447 |
| KRTAP4-8 | VCF2 | Q5XKR9 | 447 |
| KRTAP4-8 | KRTAP17-1 | Q9BYP8 | 447 |
| KRTAP4-8 | NPIPB5 | A8MRT5 | 446 |
| KRTAP4-8 | POTEM | A6NI47 | 445 |
| KRTAP4-8 | PWWP2B | Q6NUJ5 | 444 |
| KRTAP4-8 | NPIPB13 | A6NJU9 | 444 |
| KRTAP4-8 | RGPD3 | A6NKT7 | 432 |
| KRTAP4-8 | DTD2 | Q96FN9 | 431 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O14633, P02438, P04459, P05687, P05688, P08131, P08175, P0DSO2, P20730, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T750, Q5T752, Q5T754, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q8IUC1, Q8IUG1, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
282 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41097956:G:C | donor_gain | 0.8000 |
| 17:41097950:A:AC | donor_gain | 0.7900 |
| 17:41097951:C:CC | donor_gain | 0.7900 |
| 17:41097916:A:AC | donor_gain | 0.7700 |
| 17:41097917:C:CC | donor_gain | 0.7700 |
| 17:41097976:T:TA | donor_gain | 0.7300 |
| 17:41097317:C:CC | acceptor_gain | 0.7200 |
| 17:41097314:TGA:T | acceptor_gain | 0.6800 |
| 17:41097948:A:T | donor_gain | 0.6800 |
| 17:41097686:G:C | donor_gain | 0.6700 |
| 17:41097913:CAGA:C | donor_gain | 0.6700 |
| 17:41097353:T:C | donor_gain | 0.6600 |
| 17:41097355:A:T | donor_gain | 0.6600 |
| 17:41097433:AAAT:A | donor_gain | 0.6500 |
| 17:41097662:T:C | donor_gain | 0.6400 |
| 17:41097359:A:T | donor_gain | 0.6200 |
| 17:41097370:A:AC | donor_gain | 0.6200 |
| 17:41097371:C:CC | donor_gain | 0.6200 |
| 17:41097841:A:AC | donor_gain | 0.6200 |
| 17:41097842:C:CC | donor_gain | 0.6200 |
| 17:41097433:AAATC:A | donor_gain | 0.6100 |
| 17:41097366:TCTCA:T | donor_loss | 0.6000 |
| 17:41097367:CTCA:C | donor_loss | 0.6000 |
| 17:41097368:TCA:T | donor_loss | 0.6000 |
| 17:41097369:CA:C | donor_loss | 0.6000 |
| 17:41097370:AC:A | donor_loss | 0.6000 |
| 17:41097371:C:G | donor_loss | 0.6000 |
| 17:41097873:A:T | donor_gain | 0.6000 |
| 17:41097736:A:AC | donor_gain | 0.5900 |
| 17:41097737:C:CC | donor_gain | 0.5900 |
AlphaMissense
1225 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41097791:G:C | S98R | 0.659 |
| 17:41097791:G:T | S98R | 0.659 |
| 17:41097793:T:G | S98R | 0.659 |
| 17:41097532:A:G | C185R | 0.636 |
| 17:41097573:A:G | I171T | 0.629 |
| 17:41097595:A:G | C164R | 0.609 |
| 17:41097593:G:C | C164W | 0.595 |
| 17:41097866:G:C | S73R | 0.595 |
| 17:41097866:G:T | S73R | 0.595 |
| 17:41097868:T:G | S73R | 0.595 |
| 17:41097589:G:T | R166S | 0.587 |
| 17:41097580:A:G | C169R | 0.573 |
dbSNP variants (sampled 300 via entrez): RS1000410672 (17:41098540 T>C,G), RS1000744926 (17:41099552 A>G,T), RS1000794265 (17:41099694 T>A), RS1002899235 (17:41097216 A>G), RS1003250645 (17:41098181 A>T), RS1003302546 (17:41098373 C>T), RS1004979716 (17:41097028 G>C), RS1006983642 (17:41098740 C>A), RS1007313556 (17:41099818 T>C), RS1007774815 (17:41099962 T>C), RS1007808596 (17:41096948 A>G,T), RS1009390993 (17:41099613 T>G), RS1009503417 (17:41098833 C>A,G,T), RS1009853939 (17:41099731 A>G), RS1009887120 (17:41096673 C>A,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| diallyl trisulfide | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Polystyrenes | increases expression | 1 |
| Smoke | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.